The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030. A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting blood vessels. Vascular grafts are used for the surgery of vascular diseases.


June 14, 2022 — The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revasc

June 14, 2022 — A new American Heart Association scientific statement highlights the need for more data and research about sex differences in the use and response to mechanical clot removal for acute ischemic stroke and suggests a clear differentiation between sex and gender in future research.

June 13, 2022 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat serious immuno-inflammatory  diseases with significant unmet medical needs, today announced favorable results from the Company's Phase 1 clinical program for VLX-1005, a novel 12-LOX inhibitor being developed for the treatment and prevention of heparin-induced thrombocytopenia and thrombosis (HIT).

June 13, 2022 — Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial, demonstrating that the Philips endovascular system – Tack (4F) – the first and only device of its kind approved by the U.S.

June 10, 2022 — Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves compared to controls without diabetes, a comprehensive register study at the University of Gothenburg shows.

June 10, 2022 — HeartLab, the creator of Pulse — a cloud platform to help clinicians streamline reporting workflows — today announced the US launch of Pulse 2.0 at the Americ

June 10, 2022 — Setting a lower price to enter a competitive market with established brand leaders is a common penetration pricing strategy adopted by many medical device manufacturers.


Diagnostic and Interventional Cardiology (DAIC) maintains more than 50 comparison charts of product specifications from various vendors, offering a side-by-side, apples-to-apples comparison when making purchasing decisions. These charts can save hours of research, and offer links back to the websites of each vendor for additional information. The charts were created by DAIC by sending out a questionnaire to each of the vendors listed. 


June 9, 2022 — Memorial Regional Hospital recently entered elite company, becoming just the fourth hospital in the United States to earn Advanced Heart Failure Accreditation from the American College of Cardiology (ACC).

Subscribe Now